Earlier this month, the FDA banned all products being shipped to the U.S. by a Chinese API maker, and a new warning letter explains why. It appears the…

Problems at Lupin’s plant in Goa, India, hit the drugmaker’s latest earnings with a double whammy, undercutting its U.S. sales while raising costs.

Novartis is adding jobs to its biologics manufacturing operations even as the Swiss company makes cuts across other parts of its global operations.

India’s Granules bought a U.S. R&D facility in 2014 and is now ready to add manufacturing as part of plans to expand significantly in the U.S. market.…

Hospitals are dealing with a shortage of sodium bicarbonate, a drug whose active ingredient is essentially the same one that cooks know as baking soda.…

An upstate New York maker of antibiotics has scored some government incentives to help cover the cost of expanding its plant in Syracuse.

Teva is reportedly laying off hundreds of workers in the next few months at its struggling sterile injectables plant in Hungary and will sell or close the…

Germany’s Boehringer Ingelheim has opened a €70 million biologics plant in Shanghai to do contract manufacturing targeted at China's growing appetite for…

Drugmakers are closing small-molecule plants, but Sanofi is taking the process even further—it will destroy an unused plant it spent about $118 million to…

Manufacturing